T1	Participants 88 109	normotensive patients
T2	Participants 115 136	advanced malignancies
T3	Participants 286 310	advanced cancer patients
T4	Participants 411 490	we measured 12-h ambulatory BP in 41 normotensive advanced solid tumor patients
T5	Participants 571 625	mean diastolic BP (DBP) increased in both study groups
T6	Participants 748 774	but group B (600â€‰mg b.i.d.
T7	Participants 840 917	Within groups, individuals varied in BP response to sorafenib dose escalation
T8	Participants 1039 1060	normotensive patients
T9	Participants 1131 1166	Patients have intrinsic differences
